2/1/2021 8:11:20 AM
ADMA Biologics Receives FDA Approval For ADMA BioCenters Plasma Collection Facility In Knoxville
6/23/2020 7:18:20 AM
ADMA Biologics Announces Martha Demski Elected To Board
2/6/2020 8:52:07 PM
ADMA Biologics Prices Underwritten Public Offering Of 23.50 Mln Shares At $3.50/shr
1/9/2020 7:11:32 AM
ADMA Biologics Q4 Preliminary Total Revenues $11.9 Mln, Up 193%
1/7/2020 7:09:20 AM
ADMA Biologics Enters Manufacturing And Supply Deal To Produce And Sell Plasma-Derived Intermediate Fractions